Next-generation sequencing
icon-epigenetics

Next-generation sequencing

Unlock the potential of next-generation sequencing

Whether you’re performing biomarker research, gene expression studies or comprehensive genomic profiling to evaluate cancer or disease variants, next-generation sequencing (NGS) can deliver unprecedented insights, unraveling the intricacies of the genome and transcriptome. However, challenges such as workflow optimization, customization and data analysis and interpretation can hinder progress.

Navigate the complexity of the NGS world with ease by partnering with QIAGEN. Benefit from our extensive expertise, tailored solutions and market-leading informatics so you can achieve:

  • Accurate results from even the most challenging of samples
  • Faster turnaround times using streamlined and optimized workflows
  • Meaningful insights from complex NGS data
NGS

Thinking NGS? Think QIAseq!

Discover the QIAseq advantage
From challenging samples to integrated insights

Got challenging samples? Don’t write them off yet! With QIAseq, you can access the most difficult regions of the genome and derive impactful insights from the toughest of samples.

  • FFPE and liquid biopsy samples
  • Limited DNA and RNA samples
  • GC-rich regions
  • Low-frequency variants
  • Exonic regions
Corona virus
SARS-CoV-2 epidemiology and metatranscriptomics

Deeper, more holistic insights into SARS-CoV-2 biology – from viral strain evolution and phylogenetics to metatranscriptomics and gene expression – can accelerate vaccine and drug discovery research to combat the COVID-19 pandemic. Explore the full spectrum of our high-performance NGS solutions and integrated bioinformatics pipelines that collectively drive a greater understanding of the multiple facets of SARS-CoV-2 biology.

icon-cta-contact
Explore benefits of QIAseq NGS
Get in touch to see how QIAseq NGS solutions can transform your research.

Inspiration from the lab bench

See how QIAseq NGS solutions are driving research forward
  • QIAseq FastSelect enables high-quality RNA-seq
    Dr. Marie Adams from the Van Andel Institute discusses how QIAseq FastSelect technology helped conquer the challenges of generating high-quality RNA-seq data for human and bacterial co-expression studies from the same RNA sample.
  • QIAseq FastSelect increases RNA-seq sensitivity in cancer research
    Researchers from the University of Houston discuss how powerful QIAseq FastSelect rRNA removal technology transformed their research, allowing them to retrieve useful RNA-seq data from FFPE RNA.
  • Advances in immuno-oncology powered by QIAseq NGS technology
    Dr. Nathalie Labarrière from the University of Nantes describes her work using QIAseq Immune Repertoire RNA Library Kits to target colon cancer and melanoma tumors in new immuno-oncology therapies.
  • QIAseq NGS panels drive insights into pancreatic cancer risk
    Dr. Fergus Couch from the Mayo Clinic discusses how QIAseq Targeted DNA Panels played a vital role in a longitudinal case-control study on the risk of pancreatic cancer.
  • QIAseq FX technology ensures uniform coverage in cancer NGS
    Dr. Egbert Schulze from the Endocrinology and Nuclear Medicine Community Practice, Heidelberg, discusses how the all-enzymatic QIAseq FX workflow enabled uniform coverage and helped him achieve reliable sequencing results in his research.
  • QIAseq FastSelect enables high-quality RNA-seq
  • QIAseq FastSelect increases RNA-seq sensitivity in cancer research
  • Advances in immuno-oncology powered by QIAseq NGS technology
  • QIAseq NGS panels drive insights into pancreatic cancer risk
  • QIAseq FX technology ensures uniform coverage in cancer NGS

Knowledge Hub

Useful resources to fuel your research
All photos taken prior to COVID-19
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm